Benji-13

BREAKOUT CUP WITH HANDLE BUY CRIS ABOUT 9.50$

Long
NASDAQ:CRIS   Curis, Inc
19 views
1
Curis Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes

1% CAPITAL

Comments